The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. (Q39411440)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

K J Jeong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

S Y Park

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

K H Cho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J S Sohn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Y K Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

C G Park

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J W Han

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

H Y Lee

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

16 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

4279-4289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249252%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2011.595

20 January 2020

exact match

0 references

cites work

Ras and Rho GTPases: a family reunion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Dbl and the Rho GTPases activate NF kappa B by I kappa B kinase (IKK)-dependent and IKK-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

The suppressive effect of Rho kinase inhibitor, Y-27632, on oncogenic Ras/RhoA induced invasion/migration of human bladder cancer TSGH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Rho GTPases are involved in the regulation of NF-kappaB by genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Proinvasive properties of ovarian cancer ascites-derived membrane vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Promising directions for the diagnosis and management of gynecological cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Specific keynote: molecular therapeutics in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

The emerging role of lysophosphatidic acid in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

A labile repressor acts through the NFkB-like binding sites of the human urokinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Rho GTPases in cancer cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Lysophospholipids activate ovarian and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595

Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.595